GSK ESMO
Biotech

GSK CEO’s ‘scientific courage’ propels ADC toward ph. 3 tests

When Fierce last caught up with GSK’s head of oncology R&D, we were told to “stay tuned” for hotly anticipated data on a pair of ADCs.
James Waldron Apr 12, 2026 10:10am
dart board miss failure

FDA rejects Replimune’s melanoma prospect for second time

Apr 10, 2026 1:56pm
Quantum computer

'Can it deliver?': Why Big Pharma has entered the quantum realm

Apr 10, 2026 7:20am
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Vivatides; Life Bio & more

Apr 10, 2026 10:00am
Paragliding near Tu Le valley with landscape with green and yellow rice fields and blue cloudy sky North- Vietnam

Former TreeFrog CEO leaps to Orano Med—Chutes & Ladders

Apr 10, 2026 8:30am
cancer target detection radiopharma radio

China’s Oricell raises $110M for CAR-T plans ahead of IPO push

Apr 10, 2026 4:11am
More News

CAR-T drives 3 autoimmune diseases into remission in one patient

Apr 9, 2026 11:00am

Gilead pays Kymera $45M for preclinical protein degrader

Apr 9, 2026 8:45am

The 'diabolical' molecule set to become biotech's next gold rush

Apr 9, 2026 8:00am
Fierce Healthcare

States' lawsuit against RFK Jr.'s HHS overhaul moves forward

Apr 9, 2026 7:30am